Cargando…
Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses
BACKGROUND: Policymakers and healthcare stakeholders are increasingly seeking evidence to inform the policymaking process, and often use existing or commissioned systematic reviews to inform decisions. However, the methodologies that make systematic reviews authoritative take time, typically 1 to 2 ...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084365/ https://www.ncbi.nlm.nih.gov/pubmed/27793186 http://dx.doi.org/10.1186/s13643-016-0360-z |
_version_ | 1782463365942083584 |
---|---|
author | Garritty, Chantelle Stevens, Adrienne Gartlehner, Gerald King, Valerie Kamel, Chris |
author_facet | Garritty, Chantelle Stevens, Adrienne Gartlehner, Gerald King, Valerie Kamel, Chris |
author_sort | Garritty, Chantelle |
collection | PubMed |
description | BACKGROUND: Policymakers and healthcare stakeholders are increasingly seeking evidence to inform the policymaking process, and often use existing or commissioned systematic reviews to inform decisions. However, the methodologies that make systematic reviews authoritative take time, typically 1 to 2 years to complete. Outside the traditional SR timeline, “rapid reviews” have emerged as an efficient tool to get evidence to decision-makers more quickly. However, the use of rapid reviews does present challenges. To date, there has been limited published empirical information about this approach to compiling evidence. Thus, it remains a poorly understood and ill-defined set of diverse methodologies with various labels. In recent years, the need to further explore rapid review methods, characteristics, and their use has been recognized by a growing network of healthcare researchers, policymakers, and organizations, several with ties to Cochrane, which is recognized as representing an international gold standard for high-quality, systematic reviews. PURPOSE: In this commentary, we introduce the newly established Cochrane Rapid Reviews Methods Group developed to play a leading role in guiding the production of rapid reviews given they are increasingly employed as a research synthesis tool to support timely evidence-informed decision-making. We discuss how the group was formed and outline the group’s structure and remit. We also discuss the need to establish a more robust evidence base for rapid reviews in the published literature, and the importance of promoting registration of rapid review protocols in an effort to promote efficiency and transparency in research. CONCLUSION: As with standard systematic reviews, the core principles of evidence-based synthesis should apply to rapid reviews in order to minimize bias to the extent possible. The Cochrane Rapid Reviews Methods Group will serve to establish a network of rapid review stakeholders and provide a forum for discussion and training. By facilitating exchange, the group will strive to conduct research to advance the methods of rapid reviews. |
format | Online Article Text |
id | pubmed-5084365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50843652016-10-31 Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses Garritty, Chantelle Stevens, Adrienne Gartlehner, Gerald King, Valerie Kamel, Chris Syst Rev Commentary BACKGROUND: Policymakers and healthcare stakeholders are increasingly seeking evidence to inform the policymaking process, and often use existing or commissioned systematic reviews to inform decisions. However, the methodologies that make systematic reviews authoritative take time, typically 1 to 2 years to complete. Outside the traditional SR timeline, “rapid reviews” have emerged as an efficient tool to get evidence to decision-makers more quickly. However, the use of rapid reviews does present challenges. To date, there has been limited published empirical information about this approach to compiling evidence. Thus, it remains a poorly understood and ill-defined set of diverse methodologies with various labels. In recent years, the need to further explore rapid review methods, characteristics, and their use has been recognized by a growing network of healthcare researchers, policymakers, and organizations, several with ties to Cochrane, which is recognized as representing an international gold standard for high-quality, systematic reviews. PURPOSE: In this commentary, we introduce the newly established Cochrane Rapid Reviews Methods Group developed to play a leading role in guiding the production of rapid reviews given they are increasingly employed as a research synthesis tool to support timely evidence-informed decision-making. We discuss how the group was formed and outline the group’s structure and remit. We also discuss the need to establish a more robust evidence base for rapid reviews in the published literature, and the importance of promoting registration of rapid review protocols in an effort to promote efficiency and transparency in research. CONCLUSION: As with standard systematic reviews, the core principles of evidence-based synthesis should apply to rapid reviews in order to minimize bias to the extent possible. The Cochrane Rapid Reviews Methods Group will serve to establish a network of rapid review stakeholders and provide a forum for discussion and training. By facilitating exchange, the group will strive to conduct research to advance the methods of rapid reviews. BioMed Central 2016-10-28 /pmc/articles/PMC5084365/ /pubmed/27793186 http://dx.doi.org/10.1186/s13643-016-0360-z Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Garritty, Chantelle Stevens, Adrienne Gartlehner, Gerald King, Valerie Kamel, Chris Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title | Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title_full | Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title_fullStr | Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title_full_unstemmed | Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title_short | Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
title_sort | cochrane rapid reviews methods group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084365/ https://www.ncbi.nlm.nih.gov/pubmed/27793186 http://dx.doi.org/10.1186/s13643-016-0360-z |
work_keys_str_mv | AT garrittychantelle cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses AT stevensadrienne cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses AT gartlehnergerald cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses AT kingvalerie cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses AT kamelchris cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses AT cochranerapidreviewsmethodsgrouptoplayaleadingroleinguidingtheproductionofinformedhighqualitytimelyresearchevidencesyntheses |